Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetics of Pemetrexed and Carboplatin in Malignant Pleural Mesothelioma Patients

NCT00867711 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.

NCT NCT00867711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00867711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetics of Pemetrexed and Carboplatin in Malignant Pleural Mesothelioma Patients
Lead sponsor
Istituto Clinico Humanitas
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2011
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural mesothelioma